CAPR peer analysis
Capricor (CAPR) against its competitors: price, today's move, 1-year return and market value side by side.
CAPR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| DYN Dyne Therapeutics | $17.30 | 3.68% | -26.52% | – |
| EWTX Edgewise Therapeutics | $38.13 | -1.97% | 104.26% | – |
| IONS Ionis Pharmaceuticals | $41.21 | -5.31% | -44.44% | $7.23B |
| PEPG PepGen | $2.36 | -2.07% | -47.90% | – |
| PTCT PTC Therapeutics | $60.84 | 1.45% | -10.67% | $5.01B |
| SLDB Solid Biosciences | $6.20 | -2.97% | 16.76% | $664.80M |
| SRPT Sarepta Therapeutics | $18.32 | -1.64% | -21.23% | $1.97B |
| TRDA Entrada Therapeutics | $4.54 | 3.07% | -34.28% | – |
| WVE Wave Life Sciences | $3.59 | -1.10% | -56.75% | $708.05M |
| CAPR Capricor | $7.32 | 14.73% | 5.78% | $370.93M |
- CAPR's peers: DYN (Dyne Therapeutics), EWTX (Edgewise Therapeutics), IONS (Ionis Pharmaceuticals), PEPG (PepGen), PTCT (PTC Therapeutics), SLDB (Solid Biosciences), SRPT (Sarepta Therapeutics), TRDA (Entrada Therapeutics).
Updated 2026-11-03 00:01 UTC